journal
https://read.qxmd.com/read/37758802/basolateral-amygdala-neuropeptide-y-system-modulates-binge-ethanol-consumption
#1
JOURNAL ARTICLE
Stacey L Robinson, Sophie C Bendrath, Elizabeth M Yates, Todd E Thiele
Neuropeptide Y (NPY) signaling regulation of corticolimbic communication is known to modulate binge-like ethanol consumption in rodents. In this work we sought to assess the impact of intra-BLA NPY system modulation on binge-like ethanol intake and to assess the role of the NPY1R+ projection from the BLA to the mPFC in this behavior. We used "drinking-in-the-dark" (DID) procedures in C57BL6J mice to address these questions. First, the impact of intra-BLA administration of NPY on binge-like ethanol intake was assessed...
September 27, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37752223/c-reactive-protein-moderates-associations-between-racial-discrimination-and-ventromedial-prefrontal-cortex-activation-during-attention-to-threat-in-black-american-women
#2
JOURNAL ARTICLE
Aziz Elbasheir, Jennifer C Felger, Vasiliki Michopoulos, Tim D Ely, Evanthia C Wommack, Sierra E Carter, Nathaniel G Harnett, Negar Fani
Prior research has shown that racial discrimination (RD) impacts activation in threat network regions, including the ventromedial prefrontal cortex (vmPFC) and middle occipital cortex during attention to threat-relevant stimuli. However, little is known about the biological mechanisms that may modulate these effects; inflammation may be a pathway linking RD and threat network activation. As such, the current study aimed to explore whether systemic inflammation, measured by C-reactive protein (CRP) levels, may moderate the relationship between RD and activation in the vmPFC and middle occipital cortex during attention to threat...
September 26, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37752222/psilocybin-analog-4-oh-dipt-enhances-fear-extinction-and-gabaergic-inhibition-of-principal-neurons-in-the-basolateral-amygdala
#3
JOURNAL ARTICLE
Thomas J Kelly, Emma M Bonniwell, Lianwei Mu, Xiaojie Liu, Ying Hu, Vladislav Friedman, Hao Yu, Wantang Su, John D McCorvy, Qing-Song Liu
Psychedelics such as psilocybin show great promise for the treatment of depression and PTSD, but their long duration of action poses practical limitations for patient access. 4-OH-DiPT is a fast-acting and shorter-lasting derivative of psilocybin. Here we characterized the pharmacological profile of 4-OH-DiPT and examined its impact on fear extinction learning as well as a potential mechanism of action. First, we profiled 4-OH-DiPT at all 12 human 5-HT GPCRs. 4-OH-DiPT showed strongest agonist activity at all three 5-HT2A/2B/2C receptors with near full agonist activity at 5-HT2A ...
September 26, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37752221/glutamatergic-basis-of-antipsychotic-response-in-first-episode-psychosis-a-dual-voxel-study-of-the-anterior-cingulate-cortex
#4
JOURNAL ARTICLE
Lejia Fan, Liangbing Liang, Yujue Wang, Xiaoqian Ma, Liu Yuan, Lijun Ouyang, Ying He, Zongchang Li, Chunwang Li, Xiaogang Chen, Lena Palaniyappan
A subgroup of patients with schizophrenia is believed to have aberrant excess of glutamate in the frontal cortex; this subgroup is thought to show poor response to first-line antipsychotic treatments that focus on dopamine blockade. If we can identify this subgroup early in the course of illness, we can reduce the repeated use of first-line antipsychotics and potentially stratify first-episode patients to intervene early with second-line treatments such as clozapine. The use of proton magnetic resonance spectroscopy (1H-MRS) to measure glutamate and Glx (glutamate plus glutamine) may provide a means for such a stratification...
September 26, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37741905/cognition-enhancing-and-cognition-impairing-doses-of-psychostimulants-exert-opposing-actions-on-frontostriatal-neural-coding-of-delay-in-working-memory
#5
JOURNAL ARTICLE
Robert C Spencer, Andrea J Martin, David M Devilbiss, Craig W Berridge
The prefrontal cortex (PFC) and extended frontostriatal circuitry play a critical role in executive cognitive processes that guide goal-directed behavior. Dysregulation of frontostriatal-dependent cognition is implicated in a variety of cognitive/behavioral disorders, including addiction and attention deficit hyperactivity disorder (ADHD). Psychostimulants exert dose-dependent and opposing actions on frontostriatal cognitive function. Specifically, low and clinically-relevant doses improve, while higher doses associated with abuse and addiction impair, frontostriatal-dependent cognitive function...
September 23, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37741904/in-memoriam-eugene-s-paykel-md-frcp-frcpsych-fmedsci-acnp-fellow-emeritus
#6
EDITORIAL
Barbara J Sahakian, Eileen M Joyce, Trevor W Robbins
No abstract text is available yet for this article.
September 23, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37740056/influence-of-gut-microbiome-metabolites-on-cocaine-demand-and-cocaine-seeking-behavior
#7
JOURNAL ARTICLE
Amanda M Acuña, M Foster Olive
No abstract text is available yet for this article.
September 22, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37740055/the-spino-parabrachio-amygdaloid-pathway-is-critical-for-the-manifestation-of-chronic-pain
#8
JOURNAL ARTICLE
Tyler S Nelson, Heather N Allen
No abstract text is available yet for this article.
September 22, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37737273/transdiagnostic-subgroups-of-cognitive-impairment-in-early-affective-and-psychotic-illness
#9
JOURNAL ARTICLE
Julian Wenzel, Luzie Badde, Shalaila S Haas, Carolina Bonivento, Tamsyn E Van Rheenen, Linda A Antonucci, Anne Ruef, Nora Penzel, Marlene Rosen, Theresa Lichtenstein, Paris Alexandros Lalousis, Marco Paolini, Alexandra Stainton, Udo Dannlowski, Georg Romer, Paolo Brambilla, Stephen J Wood, Rachel Upthegrove, Stefan Borgwardt, Eva Meisenzahl, Raimo K R Salokangas, Christos Pantelis, Rebekka Lencer, Alessandro Bertolino, Joseph Kambeitz, Nikolaos Koutsouleris, Dominic B Dwyer, Lana Kambeitz-Ilankovic
Cognitively impaired and spared patient subgroups were identified in psychosis and depression, and in clinical high-risk for psychosis (CHR). Studies suggest differences in underlying brain structural and functional characteristics. It is unclear whether cognitive subgroups are transdiagnostic phenomena in early stages of psychotic and affective disorder which can be validated on the neural level. Patients with recent-onset psychosis (ROP; N = 140; female = 54), recent-onset depression (ROD; N = 130; female = 73), CHR (N = 128; female = 61) and healthy controls (HC; N = 270; female = 165) were recruited through the multi-site study PRONIA...
September 22, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37735504/sex-and-suicide-specific-alterations-in-the-kynurenine-pathway-in-the-anterior-cingulate-cortex-in-major-depression
#10
JOURNAL ARTICLE
Samara J Brown, Katerina Christofides, Christin Weissleder, Xu-Feng Huang, Cynthia Shannon Weickert, Chai K Lim, Kelly A Newell
Major depressive disorder (MDD) is a serious psychiatric disorder that in extreme cases can lead to suicide. Evidence suggests that alterations in the kynurenine pathway (KP) contribute to the pathology of MDD. Activation of the KP leads to the formation of neuroactive metabolites, including kynurenic acid (KYNA) and quinolinic acid (QUIN). To test for changes in the KP, postmortem anterior cingulate cortex (ACC) was obtained from the National Institute of Health NeuroBioBank. Gene expression of KP enzymes and relevant neuroinflammatory markers were investigated via RT-qPCR (Fluidigm) and KP metabolites were measured using liquid chromatography-mass spectrometry in tissue from individuals with MDD (n = 44) and matched nonpsychiatric controls (n = 36)...
September 21, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37726356/the-national-institute-on-drug-abuse-diversity-scholars-network-success-for-a-diverse-addiction-science-workforce
#11
JOURNAL ARTICLE
Albert H Avila, Jason H Weixelbaum, Kelli R Goggans, Wilson M Compton
There is a well-known lack of diversity in many Science, Technology, Engineering, and Mathematics (STEM) fields. The gap in awarded National Institutes of Health (NIH) grants for scientists from underrepresented populations at the early stages of their careers contributes significantly to this lack of diversity. The National Institute on Drug Abuse (NIDA) Diversity Scholars Network (NDSN) program implemented a new model in 2016 to provide support to underrepresented early-career investigators (ECIs) by equipping them to navigate the competitive NIH grant process...
September 19, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37723214/leveraging-ai-to-predict-substance-use-disorder-treatment-outcomes
#12
Salvatore Giorgi, Brenda Curtis
No abstract text is available yet for this article.
September 18, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37723213/in-memoriam-george-k-aghajanian-m-d-1932-2023
#13
EDITORIAL
Benjamin S Bunney
No abstract text is available yet for this article.
September 18, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37717083/gene-brain-behavior-mechanisms-underlying-autism-spectrum-disorder-implications-for-precision-psychiatry
#14
Amanda M Buch, Conor Liston
No abstract text is available yet for this article.
September 16, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37717082/people-who-binge-drink-show-neuroendocrine-tolerance-to-alcohol-cues-that-is-associated-with-immediate-and-future-drinking-results-from-a-randomized-clinical-experiment
#15
JOURNAL ARTICLE
Sara K Blaine, Clayton Ridner, Benjamin Campbell, Lily Crone, Richard Macatee, Emily B Ansell, Jennifer L Robinson, Eric D Claus
Neuroendocrine tolerance to alcohol, i.e., a blunted cortisol response to alcohol, has been linked to Ventromedial Prefrontal Cortex (VmPFC) alcohol cue reactivity and relapse risk in severe Alcohol Use Disorders (AUDs), but its role in the development of AUDs is not clear. Recent work suggests that blunted cortisol responses to alcohol cues in individuals who engage in binge drinking (BD) may play a role in motivation to consume larger amounts of alcohol, but the link between this dysregulated endocrine response and BD's neural responses to alcohol cues remains unclear...
September 16, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37715107/decreased-cnnm2-expression-in-prefrontal-cortex-affects-sensorimotor-gating-function-cognition-dendritic-spine-morphogenesis-and-risk-of-schizophrenia
#16
JOURNAL ARTICLE
Dan-Yang Zhou, Xi Su, Yong Wu, Yongfeng Yang, Luwen Zhang, Shumin Cheng, Minglong Shao, Wenqiang Li, Zhaohui Zhang, Lu Wang, Luxian Lv, Ming Li, Meng Song
Genome-wide association studies (GWASs) have reported multiple single nucleotide polymorphisms (SNPs) associated with schizophrenia, yet the underlying molecular mechanisms are largely unknown. In this study, we aimed to identify schizophrenia relevant genes showing alterations in mRNA and protein expression associated with risk SNPs at the 10q24.32-33 GWAS locus. We carried out the quantitative trait loci (QTL) and summary data-based Mendelian randomization (SMR) analyses, using the PsychENCODE dorsolateral prefrontal cortex (DLPFC) expression QTL (eQTL) database, as well as the ROSMAP and Banner DLPFC protein QTL (pQTL) datasets...
September 15, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37715106/novel-neurosteroid-therapeutics-for-post-partum-depression-perspectives-on-clinical-trials-program-development-active-research-and-future-directions
#17
REVIEW
Riah Patterson, Irina Balan, A Leslie Morrow, Samantha Meltzer-Brody
This article reviews novel neurosteroid therapeutics for post-partum depression, with a focus on their development, clinical trial data, current practices, and future directions in this exciting field. We discuss the clinical impact of brexanolone and several other neurosteroids, particularly as they relate to the treatment of postpartum depression (PPD) and major depressive disorders outside of the perinatal period. There has been increasing interest in GABA signaling and modulation as it pertains to the development of altered circuity and depressive states...
September 15, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37709943/modulators-of-gaba-a-receptor-mediated-inhibition-in-the-treatment-of-neuropsychiatric-disorders-past-present-and-future
#18
REVIEW
Scott M Thompson
The predominant inhibitory neurotransmitter in the brain, γ-aminobutyric acid (GABA), acts at ionotropic GABAA receptors to counterbalance excitation and regulate neuronal firing. GABAA receptors are heteropentameric channels comprised from subunits derived from 19 different genes. GABAA receptors have one of the richest and well-developed pharmacologies of any therapeutic drug target, including agonists, antagonists, and positive and negative allosteric modulators (PAMs, NAMs). Currently used PAMs include benzodiazepine sedatives and anxiolytics, barbiturates, endogenous and synthetic neurosteroids, and general anesthetics...
September 14, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37696990/practical-recommendations-to-improve-retention-of-underrepresented-minorities-in-science-and-medicine-an-early-career-perspective
#19
JOURNAL ARTICLE
Alexandra B Moussa-Tooks, Heather Burrell Ward
No abstract text is available yet for this article.
September 11, 2023: Neuropsychopharmacology
https://read.qxmd.com/read/37684522/leucine-rich-repeat-kinase-2-limits-dopamine-d1-receptor-signaling-in-striatum-and-biases-against-heavy-persistent-alcohol-drinking
#20
JOURNAL ARTICLE
Daniel da Silva, Aya Matsui, Erin M Murray, Adamantios Mamais, Michael E Authement, Jung Hoon Shin, Marlisa Shaw, Dorit Ron, Mark R Cookson, Veronica A Alvarez
The transition from hedonic alcohol drinking to problematic drinking is a hallmark of alcohol use disorder that occurs only in a subset of drinkers. This transition requires long-lasting changes in the synaptic drive and the activity of striatal neurons expressing dopamine D1 receptor (D1R). The molecular mechanisms that generate vulnerability in some individuals to undergo the transition are less understood. Here, we report that the Parkinson's-related protein leucine-rich repeat kinase 2 (LRRK2) modulates striatal D1R function to affect the behavioral response to alcohol and the likelihood that mice transition to heavy, persistent alcohol drinking...
September 8, 2023: Neuropsychopharmacology
journal
journal
30084
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.